$EPC

Edgewell Personal Care (EPC) reported Q2 revenue up 1.7% YoY but missed estimates, with organic revenue and EBITDA also below forecasts. Management highlighted adjusted EPS and EBITDA beating expectations, but weaker margins and EPS momentum raised concerns. The company affirmed its dividend while lowering full-year EPS guidance, focusing on cash generation amid profitability scrutiny. Analysts project $2.0B revenue and $769.1M earnings by 2029, with a 11% upside to current price.

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.

Edgewell Personal Care reported Q2 revenue of $570.1M versus $577.1M expected, with adjusted EPS of $0.72 versus $0.61 and adjusted EBITDA of $71.6M versus $72.89M. Full-year adjusted EPS guidance is $1.90 (midpoint) and EBITDA guidance $255M. Margin fell to 4.4% from 8% as brand spending rose and Wet Shave manufacturing consolidation disrupted supply.

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

Edgewell Personal Care (NYSE: EPC) reported Q2 CY2026 revenue of $570.1 million, up 1.7% year on year but below Wall Street estimates. Non-GAAP EPS was $0.72, 17.6% above consensus. The company cited improving organic net sales and North America performance. Shares were flat at $28.57 after the report.

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results Organic N

Edgewell Personal Care (NYSE: EPC) is set to report earnings Wednesday before the bell. Last quarter, it met revenue expectations with $519.5 million, flat year over year, and beat analysts on EBITDA and organic revenue. For the upcoming quarter, analysts expect 3% revenue growth after a 13.5% decline. The average analyst price target is $28 versus $27.61.

Edgewell Personal Care (EPC) shares rose 13.7% in the afternoon after the company rejected an unsolicited takeover offer from private equity firm Yellow Wood Partners, priced at $30 per share, according to reports. The board reportedly viewed the bid as too low. The stock is up 55.6% year-to-date and trades near its 52-week high.